WallStreetZenWallStreetZen

NYSE: ZTS
Zoetis Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Zoetis earnings were $2.6B for the trailing 12 months ending Mar 31, 2026, with 9.6% growth year over year. The latest ZTS earnings report on Mar 31, 2026 announced Q1 2026 earnings of $601.0M, down 0.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZTS reported annual earnings of $2.7B, with 7.5% growth.

ZTS past earnings growth

How has ZTS's earnings growth performed historically?

Company
9.62%
Industry
12.91%
Market
87.11%
ZTS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZTS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZTS's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZTS earnings history

Current Revenue
$9.5B
Current Earnings
$2.6B
Current Profit Margin
27.8%
ZTS's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ZTS Return on Equity

Current Company
62.1%
Current Industry
17.4%
Current Market
5.2%
ZTS's Return on Equity (62.4%)... subscribe to Premium to read more.
High Return on Equity Performance

ZTS Return on Assets

Current Company
17.5%
Current Industry
7.3%
ZTS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZTS announces earnings.

ZTS Return on Capital Employed

Current Company
27.01%
Current Industry
14.7%
ZTS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZTS vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZTS$4.03B$2.64B+10.12%$6.04
TEVA$3.30B$1.56BN/A$1.37
HLN$3.57B$2.25B+8.15%$0.50
VTRS$2.47B-$296.50MN/A-$0.26
NBIX$996.80M$668.60M+9.21%$6.71
View Top Pharmaceutical Stocks

Zoetis Earnings Reports & History FAQ

What were Zoetis's earnings last quarter?

On ZTS's earnings call on Invalid Date, Zoetis (NYSE: ZTS) reported Q1 2026 earnings per share (EPS) of $1.42, up 5.97% year over year. Total ZTS earnings for the quarter were $601.00 million. In the same quarter last year, Zoetis's earnings per share (EPS) was $1.34.

If you're new to stock investing, here's how to buy Zoetis stock.

Is Zoetis profitable or losing money?

As of the last Zoetis earnings report, Zoetis is currently profitable. Zoetis's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $2.64 billion, a 6.19% increase year over year.

What was ZTS's earnings growth in the past year?

As of Zoetis's earnings date in Invalid Date, Zoetis's earnings has grown 9.62% year over year. This is 3.29 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 12.91%. ZTS earnings in the past year totalled $2.64 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.